Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.59 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | RECQL | P46063 | 2/20 | 0.59 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.59 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | TNKS | O95271 | 1/20 | 0.59 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.59 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2622483 | 1.00 | TDP1 (0.61) | TDP1GLAALDH1A1HDAC3HDAC4 | |
| Chalcone SCHEMBL7008520 | 0.89 | CYP1B1 (0.73) | TDP1ALDH1A1HDAC3HDAC4HDAC1 | |
| SCHEMBL2622484 | 0.89 | HDAC2 (0.59) | TDP1GLAALDH1A1HDAC3HDAC4 | |
| SCHEMBL5598797 | 0.88 | TDP1 (0.61) | TDP1GLAALDH1A1HDAC3HDAC4 | |
| SCHEMBL5598795 | 0.88 | TDP1 (0.61) | TDP1GLAALDH1A1HDAC3HDAC4 | |
| SCHEMBL13689262 | 0.86 | HDAC3 (0.58) | TDP1GLAALDH1A1HDAC3HDAC4 | |
| SCHEMBL27727863 | 0.86 | TDP1 (0.59) | TDP1GLAALDH1A1HDAC3HDAC4 | |
| SCHEMBL8349461 | 0.85 | HDAC3 (0.56) | TDP1GLAALDH1A1HDAC3HDAC4 | |
| SCHEMBL3308815 | 0.84 | TDP1 (0.57) | TDP1GLAALDH1A1HDAC3HDAC4 | |
| SCHEMBL3308818 | 0.84 | TDP1 (0.57) | TDP1GLAALDH1A1HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108976223-A | Fused tricyclic class compound and its application in drug | 广东东阳光药业有限公司 | 2018-12-11 | — | — | CN | disclosed |
| EP-2599765-B1 | PROCESS FOR PRODUCING ALDEHYDES OR KETONES BY OXIDIZING ALCOHOLS WITH OXYGEN | UNIV EAST CHINA NORMAL (CN) | 2016-03-02 | — | — | EP | disclosed |
| US-8748669-B2 | Process for producing aldehydes or ketones by oxidizing alcohols with oxygen | EAST CHINA NORMAL UNIVERSITY (CN) | 2014-06-10 | — | — | US | disclosed |
| EP-2599765-A1 | PROCESS FOR PRODUCING ALDEHYDES OR KETONES BY OXIDIZING ALCOHOLS WITH OXYGEN | East China Normal University (CN) | 2013-06-05 | — | — | EP | disclosed |
| US-20120220792-A1 | PROCESS FOR PRODUCING ALDEHYDES OR KETONES BY OXIDIZING ALCOHOLS WITH OXYGEN | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2012-08-30 | — | — | US | disclosed |
| EP-1439001-B1 | Process for producing optically active epoxides | TOSOH CORP (JP) | 2007-07-25 | — | — | EP | disclosed |
| EP-1127616-B1 | Catalyst for asymmetric epoxidations of enones and process for producing optically active epoxide employing it | TOSOH CORP (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-1366815-B1 | Catalyst for asymmetric epoxidations of enones and process for producing optically active epoxide employing it | TOSOH CORP (JP) | 2005-12-28 | — | — | EP | disclosed |
| US-6878835-B2 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | TOSOH CORPORATION (JP) | 2005-04-12 | — | — | US | disclosed |
| EP-1439001-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | Tosoh Corporation (JP) | 2004-07-21 | — | — | EP | disclosed |
| US-6680275-B2 | COMPLEX OF OPTICALLY ACTIVE BINAPHTHOL, LANTHANUM TRIISOPROPOXIDE OXIDE, TRIPHENYLPHOSPHINE OXIDE AND CUMENE OR TERT-BUTYL HYDROPEROXIDE; OPTICAL PURITY; REACTIVITY; STABILITY | TOSOH CORPORATION (JP) | 2004-01-20 | — | — | US | disclosed |
| US-20010051737-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | TOSOH CORPORATION (JP) | 2001-12-13 | — | — | US | disclosed |
| EP-1127616-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | Tosoh Corporation (JP) | 2001-08-29 | — | — | EP | disclosed |
| US-6201123-B1 | FOR ASYMMETRIC EPOXIDATION OF ENONES; GIVES EPOXIDES HAVING AN ENHANCED OPTICAL PURITY | TECHNO POLYMER CO., LTD. (JP) | 2001-03-13 | — | — | US | disclosed |
| US-5072023-A | Reacting lactone with ester anion to form cyclohexenone ester; oxidizing or dehydrogenating the intermediate | E. R. SQUIBB & SONS, INC. (US) | 1991-12-10 | — | — | US | disclosed |
| EP-0442495-A1 | Process for preparing highly substituted phenyls | E.R. SQUIBB & SONS, INC. (US) | 1991-08-21 | — | — | EP | disclosed |
| EP-0004624-B1 | CHROMANON DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS MEDICINES AND GROWTH-PROMOTING AGENTS | BAYER AG (DE) | 1982-02-24 | — | — | EP | disclosed |
| US-4261988-A | ANTICHOLESTEROL AGENTS USED IN ANIMAL HUSBANDRY | BAYER AKTIENGESELLSCHAFT (DE) | 1981-04-14 | — | — | US | disclosed |
| EP-0004624-A2 | Chromanon derivatives, process for their preparation, and their use as medicines and growth-promoting agents | BAYER AG (DE) | 1979-10-17 | — | — | EP | disclosed |
| US-3989708-A | HYPOTENSIVE, CORONARY VESSEL DILATORS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120220792-A1 | PROCESS FOR PRODUCING ALDEHYDES OR KETONES BY OXIDIZING ALCOHOLS WITH OXYGEN | ADH1C, NOX4, NOX1 | TDP1 2582/4885GLA 4251/4885ALDH1A1 169/4885 |
| US-20010051737-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | SQLE, ENO1, GPX4 | TDP1 3343/4885GLA 1549/4885ALDH1A1 1798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.